Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide

Abstract Salusin-β is an endogenous parasympathomimetic proatherosclerotic peptide. Salusin-β was initially predicted from bioinformatic analyses and later immunologically detected in human biofluids. However, elucidation of salusin-β bioactivity has faced enormous challenges because of its unique p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kazumi Fujimoto, Akinori Hayashi, Yoshio Kodera, Tatsuya Saito, Takuya Toki, Akifumi Ogawa, Yuji Kamata, Koji Takano, Hideki Katakami, Masayoshi Shichiri
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/12e669158622491cb39e2ea5cf573602
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:12e669158622491cb39e2ea5cf573602
record_format dspace
spelling oai:doaj.org-article:12e669158622491cb39e2ea5cf5736022021-12-02T12:30:10ZIdentification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide10.1038/s41598-017-08288-02045-2322https://doaj.org/article/12e669158622491cb39e2ea5cf5736022017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08288-0https://doaj.org/toc/2045-2322Abstract Salusin-β is an endogenous parasympathomimetic proatherosclerotic peptide. Salusin-β was initially predicted from bioinformatic analyses and later immunologically detected in human biofluids. However, elucidation of salusin-β bioactivity has faced enormous challenges because of its unique physicochemical characteristics that cause it to strongly adhere to laboratory apparatus materials. In the strictest sense, the discovery of bioactive peptides is not complete until their exact native sequences have been confirmed in the peripheral circulation. In this study, we determined the plasma molecular form and levels of free salusin-β to determine its pathophysiological significance. Ultra-high-yield enrichment and preseparation of non-tryptic human plasma was followed by LC-MS/MS, and full-length salusin-β and seven different endogenous fragment sequences were identified. We established a new ELISA that specifically detects plasma free salusin-β without cross-reacting with any of its identified endogenous fragments. Free salusin-β levels exhibited a profound early morning nadir and rapidly decreased in response to parasympathetic nervous augmentation. Our technical advance in plasma native peptide analysis successfully identified a hard-to-detect bioactive peptide, salusin-β, together with its formerly unrecognized fragments, and further suggests that conventional immunological measurements of target peptides may not be fully representative.Kazumi FujimotoAkinori HayashiYoshio KoderaTatsuya SaitoTakuya TokiAkifumi OgawaYuji KamataKoji TakanoHideki KatakamiMasayoshi ShichiriNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kazumi Fujimoto
Akinori Hayashi
Yoshio Kodera
Tatsuya Saito
Takuya Toki
Akifumi Ogawa
Yuji Kamata
Koji Takano
Hideki Katakami
Masayoshi Shichiri
Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide
description Abstract Salusin-β is an endogenous parasympathomimetic proatherosclerotic peptide. Salusin-β was initially predicted from bioinformatic analyses and later immunologically detected in human biofluids. However, elucidation of salusin-β bioactivity has faced enormous challenges because of its unique physicochemical characteristics that cause it to strongly adhere to laboratory apparatus materials. In the strictest sense, the discovery of bioactive peptides is not complete until their exact native sequences have been confirmed in the peripheral circulation. In this study, we determined the plasma molecular form and levels of free salusin-β to determine its pathophysiological significance. Ultra-high-yield enrichment and preseparation of non-tryptic human plasma was followed by LC-MS/MS, and full-length salusin-β and seven different endogenous fragment sequences were identified. We established a new ELISA that specifically detects plasma free salusin-β without cross-reacting with any of its identified endogenous fragments. Free salusin-β levels exhibited a profound early morning nadir and rapidly decreased in response to parasympathetic nervous augmentation. Our technical advance in plasma native peptide analysis successfully identified a hard-to-detect bioactive peptide, salusin-β, together with its formerly unrecognized fragments, and further suggests that conventional immunological measurements of target peptides may not be fully representative.
format article
author Kazumi Fujimoto
Akinori Hayashi
Yoshio Kodera
Tatsuya Saito
Takuya Toki
Akifumi Ogawa
Yuji Kamata
Koji Takano
Hideki Katakami
Masayoshi Shichiri
author_facet Kazumi Fujimoto
Akinori Hayashi
Yoshio Kodera
Tatsuya Saito
Takuya Toki
Akifumi Ogawa
Yuji Kamata
Koji Takano
Hideki Katakami
Masayoshi Shichiri
author_sort Kazumi Fujimoto
title Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide
title_short Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide
title_full Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide
title_fullStr Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide
title_full_unstemmed Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide
title_sort identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/12e669158622491cb39e2ea5cf573602
work_keys_str_mv AT kazumifujimoto identificationandquantificationofplasmafreesalusinbanendogenousparasympathomimeticpeptide
AT akinorihayashi identificationandquantificationofplasmafreesalusinbanendogenousparasympathomimeticpeptide
AT yoshiokodera identificationandquantificationofplasmafreesalusinbanendogenousparasympathomimeticpeptide
AT tatsuyasaito identificationandquantificationofplasmafreesalusinbanendogenousparasympathomimeticpeptide
AT takuyatoki identificationandquantificationofplasmafreesalusinbanendogenousparasympathomimeticpeptide
AT akifumiogawa identificationandquantificationofplasmafreesalusinbanendogenousparasympathomimeticpeptide
AT yujikamata identificationandquantificationofplasmafreesalusinbanendogenousparasympathomimeticpeptide
AT kojitakano identificationandquantificationofplasmafreesalusinbanendogenousparasympathomimeticpeptide
AT hidekikatakami identificationandquantificationofplasmafreesalusinbanendogenousparasympathomimeticpeptide
AT masayoshishichiri identificationandquantificationofplasmafreesalusinbanendogenousparasympathomimeticpeptide
_version_ 1718394380799180800